Page last updated: 2024-08-23

ursodeoxycholic acid and Cardiovascular Diseases

ursodeoxycholic acid has been researched along with Cardiovascular Diseases in 6 studies

Research

Authors	Studies
Dohmen, K; Haruno, M; Tanaka, H	1
Drozdova, LIu; Iakhontov, DA; Kutishenko, NP; Lerman, OV; Martsevish, SIu; Nevzorova, VA; Reznik, II; Shavkuta, GV	1
Bagci, S; Demirci, H; Ozturk, K; Uygun, A	1
Bueverova, EL; Drapkina, OM	1
Abel, T; Fehér, J	1
Balmer, ML; Dufour, JF	1

3 review(s) available for ursodeoxycholic acid and Cardiovascular Diseases

Article	Year
[Ursodeoxycholic acid: A therapeutic niche in an internist's practice]. Terapevticheskii arkhiv, 2015, Volume: 87, Issue:4 Topics: Biomedical Research; Cardiovascular Diseases; Cholagogues and Choleretics; Digestive System Diseases; Humans; Internal Medicine; Ursodeoxycholic Acid	2015
[Non-alcoholic fatty liver disease and cardiovascular risk]. Orvosi hetilap, 2008, Jul-13, Volume: 149, Issue:28 Topics: Antioxidants; Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Cytokines; Exercise; Fatty Acids, Nonesterified; Fatty Liver; Feeding Behavior; Humans; Insulin Resistance; Life Style; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Metabolic Syndrome; Obesity; Triglycerides; Ursodeoxycholic Acid	2008
Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated. Swiss medical weekly, 2008, Jul-26, Volume: 138, Issue:29-30 Topics: Cardiovascular Diseases; Clofibric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Cirrhosis, Biliary; Risk Factors; Ursodeoxycholic Acid	2008

3 other study(ies) available for ursodeoxycholic acid and Cardiovascular Diseases

Article	Year
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis. Fukuoka igaku zasshi = Hukuoka acta medica, 2013, Volume: 104, Issue:10 Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; PPAR alpha; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Uric Acid; Ursodeoxycholic Acid	2013
[Ursodeoxycholic acid-enhanced efficiency and safety of statin therapy in patients with liver, gallbladder, and/or biliary tract diseases: the RACURS study]. Terapevticheskii arkhiv, 2014, Volume: 86, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Biliary Tract Diseases; Cardiovascular Diseases; Drug Synergism; Drug Therapy, Combination; Gallbladder Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Diseases; Middle Aged; Risk; Treatment Outcome; Ursodeoxycholic Acid	2014
Effect of ursodeoxycholic acid on atherosclerosis. European journal of gastroenterology & hepatology, 2015, Volume: 27, Issue:7 Topics: Anticholesteremic Agents; Atherosclerosis; Cardiovascular Diseases; Carotid Intima-Media Thickness; Evidence-Based Medicine; Humans; Treatment Outcome; Turkey; Ursodeoxycholic Acid	2015